The company is strategically expanding its product portfolio with a pipeline of new products that will form a strong foundation for future growth.
Both manufacturing facilities are based out of Benguluru, India
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
Becomes the first airline globally to develop and launch sustainable, temperature-controlled containers for the transportation of pharmaceuticals
Gilman will be responsible for all business development and portfolio strategy efforts globally.
Amarex Clinical Research guides its client to phase II of FDA trials
New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
he approved product has an estimated market size of US$ 83 million for the twelve months ending April 2022, according to IQVIA.
Subscribe To Our Newsletter & Stay Updated
